Recovery & RepairStrong EvidenceThymosin Beta-4TB-500

Thymosin Beta-4 Activates Integrin-Linked Kinase and Promotes Cardiac Cell Migration, Survival, and Cardiac Repair

Bock-Marquette I, Saxena A, White MD, Dimaio JM, Srivastava D

Nature · Vol. 432(7016) · pp. 466–472 · 2004

Landmark Nature paper demonstrating that Thymosin Beta-4 activates cardiac progenitor cells and promotes heart repair after myocardial infarction. Establishes the molecular mechanism via integrin-linked kinase (ILK) activation and shows significant reduction in infarct size in animal models.

Citation

Journal
Nature
Year
2004
DOI
10.1038/nature03000
View on DOI.org

Key Findings

1

TB4 activates integrin-linked kinase (ILK), a key survival signaling pathway in cardiac cells

2

Promotes migration of epicardial progenitor cells to the site of cardiac injury

3

Significantly reduces infarct size and improves cardiac function post-MI in animal models

4

Enhances cardiomyocyte survival under ischemic stress conditions

5

Identifies TB4 as a potential therapeutic for cardiac repair and regeneration

Methodology

In vitro cardiac cell migration and survival assays combined with in vivo mouse myocardial infarction model. Molecular pathway analysis via ILK knockdown and overexpression studies.

Limitations

Animal model data; human cardiac repair trials have not yet replicated full magnitude of benefit. Mechanism studies primarily in rodent cardiac tissue.

Tags

Thymosin Beta-4TB-500Cardiac RepairHeartILKStem CellMyocardial Infarction

Educational use only. Research summaries are provided for informational purposes. Always consult the original publication and a qualified healthcare provider before making clinical decisions.

Build a protocol around this research

Our AI Advisor incorporates the latest research to build a personalized peptide protocol for your goals.

Start Assessment